Recombinant human tissue plasminogen activator without heparin is effective in the treatment of hepatic veno-occlusive disease

Haematologica. 1999 Feb;84(2):191-2.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Female
  • Fibrinolytic Agents / therapeutic use*
  • Heparin / therapeutic use
  • Hepatic Veno-Occlusive Disease / drug therapy*
  • Humans
  • Male
  • Middle Aged
  • Recombinant Proteins / therapeutic use
  • Tissue Plasminogen Activator / therapeutic use*
  • Treatment Outcome

Substances

  • Fibrinolytic Agents
  • Recombinant Proteins
  • Heparin
  • Tissue Plasminogen Activator